Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The “Anticipate” study

医学 瞬态弹性成像 门脉高压 静脉曲张 门静脉压 内科学 食管静脉曲张 肝硬化 人口 列线图 风险评估 胃肠病学 计算机安全 计算机科学 环境卫生 肝纤维化
作者
Juan G. Abraldeṣ,Christophe Bureau,Horia Ştefănescu,Salvador Augustín,Michael Ney,Hélène Blasco,Bogdan Procopeț,Jaime Bosch,Joan Genescà,Annalisa Berzigotti
出处
期刊:Hepatology [Lippincott Williams & Wilkins]
卷期号:64 (6): 2173-2184 被引量:354
标识
DOI:10.1002/hep.28824
摘要

In patients with compensated advanced chronic liver disease (cACLD), the presence of clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears prognostic and therapeutic implications. Our aim was to develop noninvasive tests‐based risk prediction models to provide a point‐of‐care risk assessment of cACLD patients. We analyzed 518 patients with cACLD from five centers in Europe/Canada with paired noninvasive tests (liver stiffness measurement [LSM] by transient elastography, platelet count, and spleen diameter with calculation of liver stiffness to spleen/platelet score [LSPS] score and platelet‐spleen ratio [PSR]) and endoscopy/hepatic venous pressure gradient measurement. Risk of CSPH, varices, and VNT was modeled with logistic regression. All noninvasive tests reliably identified patients with high risk of CSPH, and LSPS had the highest discrimination. LSPS values above 2.65 were associated with risks of CSPH above 80%. None of the tests identified patients with very low risk of all‐size varices, but both LSPS and a model combining TE and platelet count identified patients with very low risk (<5%) risk of VNT, suggesting that they could be used to triage patients requiring screening endoscopy. LSPS values of <1.33 were associated with a <5% risk of VNT, and 26% of patients had values below this threshold. LSM combined with platelet count predicted a risk <5% of VNT in 30% of the patients. Nomograms were developed to facilitate point‐of‐care risk assessment. Conclusion : A significant proportion of patients with a very high risk of CSPH, and a population with a very low risk of VNT can be identified with simple, noninvasive tests, suggesting that these can be used to individualize medical care. (H epatology 2016;64:2173‐2184).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
molihuakai的应助被科研通管家采纳,获得10
刚刚
Owen的应助被科研通管家采纳,获得10
刚刚
大模型的应助被科研通管家采纳,获得10
刚刚
JamesPei的应助被科研通管家采纳,获得10
刚刚
ZIYE的应助被科研通管家采纳,获得10
1秒前
ZIYE的应助被科研通管家采纳,获得10
1秒前
wcl完成签到,获得积分10
1秒前
所所的应助被科研通管家采纳,获得10
1秒前
不倦的应助被科研通管家采纳,获得50
1秒前
梨有理想完成签到 ,获得积分10
1秒前
大模型的应助被科研通管家采纳,获得10
1秒前
传奇3的应助被科研通管家采纳,获得10
1秒前
星辰大海的应助被科研通管家采纳,获得10
1秒前
默默zzz完成签到 ,获得积分10
1秒前
打打的应助被科研通管家采纳,获得10
1秒前
2秒前
ket的应助被喜肥采纳,获得10
2秒前
Hello的应助被科研通管家采纳,获得10
2秒前
田様的应助被科研通管家采纳,获得10
2秒前
在水一方的应助被科研通管家采纳,获得10
2秒前
小蘑菇的应助被科研通管家采纳,获得10
2秒前
霖29发布了新的文献求助10
2秒前
所所的应助被科研通管家采纳,获得10
2秒前
2秒前
2秒前
大个的应助被科研通管家采纳,获得10
2秒前
3秒前
打打的应助被科研通管家采纳,获得10
3秒前
英俊的铭的应助被科研通管家采纳,获得10
3秒前
今后的应助被科研通管家采纳,获得10
3秒前
大模型的应助被科研通管家采纳,获得10
3秒前
英姑的应助被科研通管家采纳,获得10
3秒前
天天快乐的应助被科研通管家采纳,获得10
3秒前
慕青的应助被科研通管家采纳,获得10
3秒前
顾矜的应助被科研通管家采纳,获得10
4秒前
酷波er的应助被科研通管家采纳,获得10
4秒前
科研通AI65的应助被pipipiKimi采纳,获得10
4秒前
丰富语蕊的应助被科研通管家采纳,获得10
4秒前
muxiangrong的应助被科研通管家采纳,获得10
4秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185762
求助须知:如何正确求助?哪些是违规求助? 9574458
关于积分的说明 21836217
捐赠科研通 7783574
什么是DOI,文献DOI怎么找? 3434651
关于科研通互助平台的介绍 2559017
邀请新用户注册赠送积分活动 2481466